Related Posts

ResApp Health (ASX:RAP) – managing respiratory disease and sleep apnoea
07 Dec 2020 - ResApp Health Limited (ASX:RAP) CEO and Managing Director Dr Tony Keating provides an update on the company's growing suite of apps for the diagnosis and management of respiratory conditions and sleep apnoea, discussing its launch of the ResAppDx smartphone-based acute respiratory diagnostic test.
Read More
Investing in childcare
19 Jun 2024 - Patrick Bell, CEO and Director of Finexia Financial Group (ASX:FNX) speaks to Garry Crole, CEO and Managing Director of Sequoia Financial Group (ASX:SEQ). Topics discussed include the company's Childcare Income Fund and its lending business.
Read More
Immunotherapy and autoimmune diseases: A promising new approach
10 Mar 2025 - Addressing Chronic Conditions with Targeted Treatments
Read More
Unveiling Lincoln Minerals: Revitalizing Kookaburra Gully Graphite Project
07 Nov 2023 - Newly appointed Lincoln Minerals (ASX:LML) CEO Jonathon Trewartha discusses their focus on developing the Kookaburra Gully Graphite Project in South Australia. He highlights plans to expand the resource through drilling, aiming for a 10-year mine life, and addresses the company's response to global market changes impacting graphite production.
Read More
Cynata Therapeutics’ breakthrough in regenerative medicine
14 Mar 2024 - Delve into the cutting-edge realm of regenerative medicine with Kilian Kelly, CEO of Cynata Therapeutics. Learn how their stem cell innovations are shaping the future of healthcare.
Read More
Capral (ASX:CAA) FY20 results & outlook
23 Apr 2021 - Capral Limited (ASX:CAA) Managing Director Tony Dragicevich talks about the company's strong FY20 results despite COVID, its product mix, operating environment and outlook.
Read More
Mainstream Group Holdings (ASX:MAI) FY20 results & outlook
30 Sep 2020 - Mainstream Group Holdings Limited (ASX:MAI) CEO Martin Smith provides an update on the company's FY20 results, the impact of COVID-19, strategy and outlook.
Read More
NT Government gives green light for Beetaloo gas production
08 May 2023 - Empire Energy Group Limited (ASX:EEG) Managing Director Alex Underwood discusses NT Government approval for fracking in the Beetaloo Basin, exemptions for small producers, traditional owners, pipelines, government funding and the company's pilot project.
Read More
BARD1 Life Sciences (ASX:BD1) – detecting cancer earlier to save lives, July 2021
29 Jul 2021 - BARD1 Life Sciences Limited (ASX:BD1) CEO Dr Leearne Hinch introduces the company, discussing its recent capital raising and share purchase plan.
Read More
Encouraging results for Immutep’s cancer therapies
25 Mar 2024 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt provides an update on the company's pipeline of clinical trials, focusing on results in head and neck cancer, lung cancer and breast cancer.
Read More